Joshua Saul Davis (Joshua Davis, J Davies, J S Davis, Joshua S Davis)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 39

Top Topics

Total Hip Arthroplasty

Staphylococcus Aureus

Top Venues

The Medical journal of Australia

Open forum infectious diseases

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Laurens Manning, Alexander Rofe, Eugene Athan, Stephen D Gill, Piers Yates, Darcie Cooper, Joshua Saul Davis, Craig Aboltins, null null
Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee: A Longitudinal, Prospective Observational Study. The Journal of bone and joint surgery. American volume 106 (13) (2024)
Burcu Isler, Natalie Niessen, David Campbell, Andrew D Toms, Nick Daneman, Laurens Manning, Joshua Saul Davis
Addressing important evidence gaps in the management of prosthetic joint infection: clinician attitudes and equipoise. ANZ journal of surgery 94 (7-8) (2024)
Neta Petersiel, Stefano G Giulieri, Diane S Daniel, Sook-Ha Fan, Selvi C Ersoy, Joshua Saul Davis, Arnold S Bayer, Benjamin P Howden, Steven Y C Tong, null null
Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial. Antimicrobial agents and chemotherapy 68 (7) (2024)
Joshua Saul Davis, David Dewar, Laurens Manning
Prosthetic joint infection diagnosis in an age of changing clinical patterns of infection and new technologies. The Medical journal of Australia 220 (5) (2024)
Neta Petersiel, Stefano G Giulieri, Diane S Daniel, Sook-Ha Fan, Selvi C Ersoy, Joshua Saul Davis, Arnold S Bayer, Benjamin P Howden, Steven Y C Tong, null null
Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial. Antimicrobial agents and chemotherapy 68 (7) (2024)
Joshua Saul Davis, David Dewar, Laurens Manning
Prosthetic joint infection diagnosis in an age of changing clinical patterns of infection and new technologies. The Medical journal of Australia (2024)
Neta Petersiel, Stefano G Giulieri, Diane S Daniel, Sook-Ha Fan, Selvi C Ersoy, Joshua Saul Davis, Arnold S Bayer, Benjamin P Howden, Steven Y C Tong, null null
Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial. Antimicrobial agents and chemotherapy 68 (7) (2024)
Joshua Saul Davis, David Dewar, Laurens Manning
Prosthetic joint infection diagnosis in an age of changing clinical patterns of infection and new technologies. The Medical journal of Australia 220 (5) (2024)
Laurens Manning, Alexander Rofe, Eugene Athan, Stephen D Gill, Piers Yates, Darcie Cooper, Joshua Saul Davis, Craig Aboltins, null null
Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee: A Longitudinal, Prospective Observational Study. The Journal of bone and joint surgery. American volume (2024)
Joshua Saul Davis, David Dewar, Laurens Manning
Prosthetic joint infection diagnosis in an age of changing clinical patterns of infection and new technologies. The Medical journal of Australia 220 (5) (2024)
Burcu Isler, Natalie Niessen, David Campbell, Andrew D Toms, Nick Daneman, Laurens Manning, Joshua Saul Davis
Addressing important evidence gaps in the management of prosthetic joint infection: clinician attitudes and equipoise. ANZ journal of surgery (2024)
Neta Petersiel, Stefano G Giulieri, Diane S Daniel, Sook-Ha Fan, Selvi C Ersoy, Joshua Saul Davis, Arnold S Bayer, Benjamin P Howden, Steven Y C Tong, null null
Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial. Antimicrobial agents and chemotherapy (2024)
Amy Legg, Matthew A Roberts, Jane Davies, Alan Cass, Niamh Meagher, Archana Sud, Vered Daitch, Yael Dishon Benattar, Dafna Yahav, Mical Paul, Chen Xinxin, Yeo He Ping, David Lye, Russel Lee, J Owen Robinson, Hong Foo, Adrian R Tramontana, Narin Bak, Adelaide Grenfell, Benjamin A Rogers, Ying Li, Neela Joshi, Matthew O'Sullivan, Genevieve McKew, Niladri Ghosh, Kellie Schneider, Natasha E Holmes, Ravindra Dotel, Timothy Chia, Sophia Archuleta, Simon Smith, Morgyn S Warner, Christina Titin, Shirin Kalimuddin, Jason Alexander Roberts, Steven Y C Tong, Joshua Saul Davis, null null
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis. Open forum infectious diseases 10 (7) (2023)
Andrew Henderson, Matthew Pellan Cheng, Ka Lip Chew, Geoffrey W Coombs, Joshua Saul Davis, Jennifer M Grant, Dan Gregson, Stefano G Giulieri, Benjamin Peter Howden, Todd C Lee, Vi Nguyen, Jocelyn M Mora, Susan C Morpeth, James O Robinson, Steven Y C Tong, Sebastiaan J Van Hal, null null
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus. The Journal of antimicrobial chemotherapy (2023)
Amy Legg, Jason A Roberts, Matthew A Roberts, Alan Cass, Jane Davies, Steven Y C Tong, Joshua Saul Davis
Avoiding misclassification of acute kidney injury: Timing is everything. Nephrology (Carlton, Vic.) (2023)
Josh Hanson, Sharna Radlof, Margaret Littlejohn, Allison Hempenstall, Ros Edwards, Yoko Nakata, Sandra Gregson, Richard Hayes, Simon Smith, Melita McKinnon, Paula Binks, Steven Y C Tong, Jane Davies, Joshua Saul Davis
Hepatitis B genotypes in Aboriginal and Torres Strait Islander Australians: correlation with clinical course and implications for management. Internal medicine journal (2023)
Tanya J Symons, Nicola Straiton, Rosie Gagnon, Roberta Littleford, Anita J Campbell, Asha C Bowen, Adam G Stewart, Steven Y C Tong, Joshua Saul Davis
Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial. Trials 23 (1) (2022)
A J Campbell, R Dotel, M Braddick, P N Britton, D P Eisen, J R Francis, S Lynar, B McMullan, N Meagher, J Nelson, M V N O'Sullivan, D J Price, J O Robinson, A Whelan, Steven Y C Tong, A C Bowen, Joshua Saul Davis
Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)-an open-labelled pilot randomized controlled trial. JAC-antimicrobial resistance 4 (1) (2022)
Joshua Saul Davis, Sarah Metcalf, Benjamin Clark, J Owen Robinson, Paul Huggan, Chris Luey, Stephen McBride, Craig Aboltins, Renjy Nelson, David Campbell, L Bogdan Solomon, Kellie Schneider, Mark R Loewenthal, Piers Yates, Eugene Athan, Darcie Cooper, Babak Rad, Tony Allworth, Alistair Reid, Kerry Read, Peter Leung, Archana Sud, Vana Nagendra, Roy Chean, Chris Lemoh, Nora Mutalima, Ton Tran, Kate Grimwade, Marjoree Sehu, David Looke, Adrienne Torda, Thi Aung, Steven Graves, David L Paterson, Laurens Manning
Predictors of Treatment Success After Periprosthetic Joint Infection: 24-Month Follow up From a Multicenter Prospective Observational Cohort Study of 653 Patients. Open forum infectious diseases 9 (3) (2022)
Joshua Saul Davis, Sarah Metcalf, David L Paterson, James O Robinson, Benjamin Clarke, Laurens Manning
Proposed empiric antibiotic therapy for prosthetic joint infections: an analysis of the Prosthetic Joint Infection in Australia and New Zealand, Observational (PIANO) cohort. Internal medicine journal 52 (2) (2022)
Joshua Saul Davis, Laurant Xi Kang, Laurens Manning, David Dewar
Clinician-driven research priorities in bone and joint infection: perspectives of orthopaedic surgeons and infectious diseases physicians. ANZ journal of surgery 92 (11) (2022)
Tanya J Symons, Nicola Straiton, Rosie Gagnon, Roberta Littleford, Anita J Campbell, Asha C Bowen, Adam G Stewart, Steven Y C Tong, Joshua Saul Davis
Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial. Trials 23 (1) (2022)
Tanya J Symons, Nicola Straiton, Rosie Gagnon, Roberta Littleford, Anita J Campbell, Asha C Bowen, Adam G Stewart, Steven Y C Tong, Joshua Saul Davis
Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial. Trials 23 (1) (2022)
Tanya Symons, Joshua Saul Davis
Creating concise and readable patient information sheets for interventional studies in Australia: are we there yet? Trials 23 (1) (2022)
Emma J Baillie, Gregory Merlo, Parker J Magin, Amanda Tapley, Katie J Mulquiney, Joshua Saul Davis, Alison Fielding, Andrew Davey, Elizabeth G Holliday, Jean Ball, Neil Spike, Kristen FitzGerald, Mieke L van Driel
Antibiotic prescribing for upper respiratory tract infections and acute bronchitis: a longitudinal analysis of general practitioner trainees. Family practice 39 (6) (2022)
Jessica Howell, James S Ward, Jane Davies, Paul J Clark, Joshua Saul Davis
Hepatocellular carcinoma in Indigenous Australians: a call to action. The Medical journal of Australia 214 (5) (2021)
Asha C Bowen, Steven Y C Tong, Joshua Saul Davis
Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID-19. The Medical journal of Australia 215 (2) (2021)
Adam G Stewart, David L Paterson, Barnaby Edward Young, David Chien Boon Lye, Joshua Saul Davis, Kellie Schneider, Mesut Yilmaz, Rumeysa Dinleyici, Naomi Runnegar, Andrew Henderson, Sophia Archuleta, Shirin Kalimuddin, Brian M Forde, Mark David Chatfield, Michelle J Bauer, Jeffrey Lipman, Tiffany Harris-Brown, Patrick N A Harris, null null
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2). Open forum infectious diseases 8 (8) (2021)
Amit Atrey, Amir Khoshbin, Ola Rolfson, David G Campbell, Gavin Wood, Eric R Bohm, Christopher Jones, Christopher Kandel, Joshua Saul Davis, Nipun Atri, Hesham Abdelbary, Dirk Jan F Moojen, Michael J Dunbar, Laurens Manning, Elizabeth W Paxton, Piers J Yates, James P Waddell, Bheeshma Ravi, Mike R Reed, null null
Infection: The Final Frontier of Arthroplasty Management: A Proposal for a Global Periprosthetic Joint Infection Registry from a Multinational Collaborative Group, the GAIA (Global Arthroplasty Infection Association). The Journal of bone and joint surgery. American volume 103 (6) (2021)
Joshua Saul Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical microbiology reviews 33 (3) (2020)
Jiajun Liu, Steven Y C Tong, Joshua Saul Davis, Nathaniel James Rhodes, Marc H Scheetz, null null
Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study. Open forum infectious diseases 7 (12) (2020)
Joshua Saul Davis, Ginger Chu, Prabuddhua Pathinayake, Denise Jones, Phil Giffard, Lisa Macera, Peter Choi, Nathan W Bartlett
Seroprevalence of Torque Teno Virus in hemodialysis and renal transplant patients in Australia: A cross-sectional study. Transplant infectious disease : an official journal of the Transplantation Society 22 (5) (2020)
J S Davis, M Young, C Marshall, J Tate-Baker, M Madison, S Sharma, C Silva, T Jones, Joshua Saul Davis
Minimal Compared With Standard Monitoring During Sofosbuvir-Based Hepatitis C Treatment: A Randomized Controlled Trial. Open forum infectious diseases 7 (2) (2020)
Joshua Saul Davis, David Ferreira, Justin T Denholm, Steven Y C Tong
Clinical trials for the prevention and treatment of COVID-19: current state of play. The Medical journal of Australia 213 (2) (2020)
Richard P Sullivan, Jane Davies, Paula Binks, Roslyn Gundjirryiir Dhurrkay, George Garambaka Gurruwiwi, Sarah Mariyalawuy Bukulatjpi, Melita McKinnon, Kelly Hosking, Margaret Littlejohn, Kathy Jackson, Stephen Locarnini, Joshua Saul Davis, Steven Y C Tong
Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia. Journal of viral hepatitis 27 (4) (2019)
Joshua Saul Davis, Parker J Magin, Mieke L van Driel
The false dichotomy of viral versus bacterial aetiology in upper respiratory tract infections. The Medical journal of Australia 211 (3) (2019)
Joshua Saul Davis, Cheryl A Jones, Allen C Cheng, Benjamin P Howden
Australia's response to the global threat of antimicrobial resistance: past, present and future. The Medical journal of Australia 211 (3) (2019)
Jane Davies, Emma L Smith, Margaret Littlejohn, Rosalind Edwards, Vitina Sozzi, Kathy Jackson, Katie Mcguire, Paula Binks, Benjamin C Cowie, Stephen Locarnini, Joshua Saul Davis, Steven Y C Tong
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study. Open forum infectious diseases 6 (11) (2019)
Steven Y C Tong, Jane Nelson, David L Paterson, Vance G Fowler, Benjamin P Howden, Allen C Cheng, Mark Chatfield, Jeffrey Lipman, Sebastian Van Hal, Matthew O'Sullivan, James O Robinson, Dafna Yahav, David Lye, Joshua Saul Davis, null null
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials 17 (2016)
Jane Davies, Sarah Bukulatjpi, Suresh Sharma, Luci Caldwell, Vanessa Johnston, Joshua Saul Davis
Development of a Culturally Appropriate Bilingual Electronic App About Hepatitis B for Indigenous Australians: Towards Shared Understandings. JMIR research protocols 4 (2) (2015)